Nasdaq: IONS
Ionis Pharmaceuticals insiders
The officers, directors and 10% owners of Ionis Pharmaceuticals, Inc. who hold the most stock, valued at the live IONS price.
$27.22
IONS today −$170K (−0.62%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 3
- Their IONS stock
- $10.9M
- Market value
- $4.53B
- Held by ranked insiders
- 0.24%
Insiders by value of IONS holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Brett P. Monia | Chief Executive Officer | 242,760 | $6.6M | 0.15% | 11833rd |
| 2 | Michael R. Hayden | Director | 105,298 | $2.9M | <0.1% | 5519th |
| 3 | Joan E. Herman | Director | 51,306 | $1.4M | <0.1% | 10401st |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Ionis Pharmaceuticals; see each profile for the filing.